- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-005142-21. Displaying page 1 of 1.
|EudraCT Number: 2014-005142-21||Sponsor Protocol Number: MLN1202-2005||Start Date*: 2015-05-20|
|Sponsor Name:Takeda Development Centre Europe Limited|
|Full Title: A Multicenter, Randomized, Double Blind, Placebo Controlled, Proof of Concept, Phase 2 Study to Evaluate the Efficacy and Safety of Weekly Subcutaneous MLN1202, in Improving Diabetic Nephropathy Su...|
|Medical condition: Diabetic Nephropathy: Adults (age 18 - 90 years inclusive) with type 2 diabetes, an eGFR of 25-59 mL/min/1.73 m2, and with macroalbuminuria (>300 mg/g) will be randomized.|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: SK (Prematurely Ended) AT (Prematurely Ended) DK (Prematurely Ended)|
|Trial results: (No results available)|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.